Showing results 1 to 2 of 2
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Activity of brigatinib (BRG) in crizotinib (CRZ) resistant patients (pts) according to ALK mutation status Proceeding/Conference:Journal of Clinical Oncology | 2016 | ||
| 2020 |
| Title | Author(s) | Issue Date | |
|---|---|---|---|
Activity of brigatinib (BRG) in crizotinib (CRZ) resistant patients (pts) according to ALK mutation status Proceeding/Conference:Journal of Clinical Oncology | 2016 | ||
| 2020 |